Tech Coast Angels (TCA) is one of the largest angel investor groups in the U.S, with the Los Angeles network (TCA:LA) boasting over 150 members. Tech Coast Angels actively seeks great startups to fund and for members to join our prolific network.
Providing more than just money, with its 450+ members, TCA brings connections, knowledge, mentoring and operational assistance to bold early-stage entrepreneurs with game-changing ideas.
Let us help you to turn your vision into a sustainable and successful business!
Octagon is developing targeted medicines that specifically inhibit disease-driving processes based on a novel disease pathway. The company has 3 assets in active development. These medicines have the potential to address severe autoimmune diseases including Lupus and Arthritis and rare diseases such as Pemphigus/Pemphigoid, Myasthenia, and Scleroderma. Octagon's most advanced drug candidate is a monoclonal antibody. These new medicines are the result of a differentiated drug discovery platform that directly makes use of human clinical samples to identify disease-driving biological pathways. This platform has formed the basis for a multi-year funded partnership with Novo Nordisk, a top-ten multinational pharmaceutical company.
Edge Case Capital Partners is a venture capital group dedicated to supporting innovation and creating impact in early-stage software startups. We are a generalist firm with interests in AI technology and FinTech.